STOCK TITAN

NOVO NORDISK A/S B NEW (NONOF) Financials

NONOF OTC
FY2025 annual
Revenue $48.6B +20.5% YoY
Net Income $16.1B +14.8% YoY
EPS (Diluted) $3.62 +15.2% YoY
Free Cash Flow $9.3B -9.6% YoY
Market Cap $171.9B as of Oct 29, 2026
Price / Sales 3.5x on $48.6B revenue, FY2025
Price / Earnings 10.7x on $16.1B net income, FY2025
Price / Book 5.6x on $30.5B equity, Q4 FY2025

A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Oct 29, 2026; every other figure is from the SEC filings on this page. Not financial advice.

Source SEC Filings (20-F/6-K) Latest period FY2025, ended Dec 31, 2025 Reported Currency USD FYE December

Newest figures come from the 20-F for FY2025, filed Feb 4, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the NONOF SEC filings page.

NOVO NORDISK A/S B NEW (NONOF) reported $48.6B in revenue for fiscal year 2025, up 20.5% from the prior fiscal year. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 11 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Financial Health Signals

Financial health score not available

NOVO NORDISK A/S B NEW does not currently provide enough eligible data for a peer-relative financial health score, so none is published. The signals and metrics below are current.

Altman Z-Score Safe
3.63

NOVO NORDISK A/S B NEW scores 3.63, well above the 2.99 safe threshold. The largest contribution to the score comes from a market capitalization of $171.9B against total liabilities of $54.8B. This indicates low bankruptcy risk based on profitability, leverage, and asset efficiency.

Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.

Piotroski F-Score Partial
4/8

NOVO NORDISK A/S B NEW passes 4 of 8 computable financial strength tests (1 of the nine could not be computed from available data). 3 of 4 profitability signals pass, 1 of 2 leverage/liquidity signals pass, neither operating efficiency signal passes.

Earnings Quality Cash-Backed
1.16x

For every $1 of reported earnings, NOVO NORDISK A/S B NEW generates $1.16 in operating cash flow ($18.7B OCF vs $16.1B net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.

Interest Coverage Safe
30.34x

NOVO NORDISK A/S B NEW earns $30.34 in operating income for every $1 of interest expense ($20.1B vs $661.1M). This wide margin provides strong safety for debt servicing, even if earnings decline temporarily.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue
$48.6B
YoY+20.5%
5Y CAGR+18.4%
10Y CAGR+12.0%

NOVO NORDISK A/S B NEW generated $48.6B in revenue in fiscal year 2025. This represents an increase of 20.5% from the prior year.

EBITDA
$23.5B
YoY+14.9%
5Y CAGR+19.0%
10Y CAGR+11.9%

NOVO NORDISK A/S B NEW's EBITDA was $23.5B in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 14.9% from the prior year.

Net Income
$16.1B
YoY+14.8%
5Y CAGR+18.4%
10Y CAGR+12.2%

NOVO NORDISK A/S B NEW reported $16.1B in net income in fiscal year 2025. This represents an increase of 14.8% from the prior year.

EPS (Diluted)
$3.62
YoY+15.2%

NOVO NORDISK A/S B NEW earned $3.62 per diluted share (EPS) in fiscal year 2025. This represents an increase of 15.2% from the prior year.

Cash & Balance Sheet

Free Cash Flow
$9.3B
YoY-9.6%
5Y CAGR+4.1%
10Y CAGR+6.8%

NOVO NORDISK A/S B NEW generated $9.3B in free cash flow in fiscal year 2025, representing cash available after capex. This represents a decrease of 9.6% from the prior year.

Cash & Debt
$4.2B
YoY+91.4%
5Y CAGR+15.7%
10Y CAGR+6.1%

NOVO NORDISK A/S B NEW held $4.2B in cash against $36.2B in long-term debt as of fiscal year 2025.

Shares Outstanding
Diluted avg 4.45B

NOVO NORDISK A/S B NEW had a weighted average of 4.45B diluted shares in fiscal year 2025; the shares outstanding count is not reported for that period.

Dividends Per Share

Not reported for fiscal year 2025.

Margins & Returns

Gross Margin
81.0%
YoY-3.7pp
5Y change-2.5pp
10Y change-4.0pp

NOVO NORDISK A/S B NEW's gross margin was 81.0% in fiscal year 2025, indicating the percentage of revenue retained after direct costs. This is down 3.7 percentage points from the prior year.

Operating Margin
41.3%
YoY-2.9pp
5Y change-1.3pp
10Y change-4.5pp

NOVO NORDISK A/S B NEW's operating margin was 41.3% in fiscal year 2025, reflecting core business profitability. This is down 2.9 percentage points from the prior year.

Net Margin
33.1%
YoY-1.6pp
5Y change-0.1pp
10Y change+0.8pp

NOVO NORDISK A/S B NEW's net profit margin was 33.1% in fiscal year 2025, showing the share of revenue converted to profit. This is down 1.6 percentage points from the prior year.

Return on Equity
52.8%
YoY-17.6pp
5Y change-13.7pp
10Y change-21.4pp

NOVO NORDISK A/S B NEW's ROE was 52.8% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is down 17.6 percentage points from the prior year.

Capital Allocation

R&D Spending
$8.2B
YoY+22.6%
5Y CAGR+26.3%
10Y CAGR+15.2%

NOVO NORDISK A/S B NEW invested $8.2B in research and development in fiscal year 2025. This represents an increase of 22.6% from the prior year.

Share Buybacks
$218.1M
YoY-92.2%
5Y CAGR-39.9%
10Y CAGR-21.7%

NOVO NORDISK A/S B NEW spent $218.1M on share buybacks in fiscal year 2025, returning capital to shareholders by reducing shares outstanding. This represents a decrease of 92.2% from the prior year.

Capital Expenditures
$9.5B
YoY+44.4%
5Y CAGR+58.1%
10Y CAGR+28.7%

NOVO NORDISK A/S B NEW invested $9.5B in capex in fiscal year 2025, funding long-term assets and infrastructure. This represents an increase of 44.4% from the prior year.

NONOF Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

NONOF annual income statement
MetricFY2520-FFY2420-FFY2320-FFY2220-FFY2120-FFY2020-FFY1920-FFY1820-FFY1720-FFY1620-FFY1520-F
Revenue$48.6B+20.5%$40.3B+16.9%$34.5B+35.4%$25.5B+18.8%$21.4B+2.7%$20.9B+13.8%$18.3B+6.8%$17.2B-4.9%$18.0B+13.7%$15.9B+1.0%$15.7B
Cost of Revenue$9.2B+49.5%$6.2B+16.4%$5.3B+29.7%$4.1B+13.7%$3.6B+4.7%$3.4B+14.0%$3.0B+11.7%$2.7B-5.0%$2.8B+16.7%$2.4B+3.5%$2.4B
Gross Profit$39.3B+15.2%$34.1B+17.0%$29.2B+36.5%$21.4B+19.8%$17.8B+2.3%$17.4B+13.8%$15.3B+5.9%$14.5B-4.8%$15.2B+13.1%$13.4B+0.6%$13.3B
R&D Expenses$8.2B+22.6%$6.7B+38.6%$4.8B+39.2%$3.5B+27.9%$2.7B+6.4%$2.5B+18.9%$2.1B-5.9%$2.3B+0.4%$2.3B+9.5%$2.1B+4.4%$2.0B
Operating Income$20.1B+12.6%$17.8B+17.0%$15.2B+41.4%$10.8B+20.6%$8.9B+0.3%$8.9B+12.8%$7.9B+8.8%$7.2B-8.3%$7.9B+15.0%$6.9B-4.5%$7.2B
EBITDA$23.5B+14.9%$20.5B+23.2%$16.6B+40.6%$11.8B+20.1%$9.8B0.0%$9.8B+12.7%$8.7B+11.3%$7.9B-6.7%$8.4B+14.9%$7.3B-3.9%$7.6B
Interest Expense$661.1M+190.4%$227.6M+183.0%$80.4M+47.9%$54.4M+23.6%$44.0M-31.4%$64.1M+93.9%$33.1M+153.4%$13.0M-10.2%$14.5M+57.5%$9.2M-5.4%$9.7M
Income Tax$4.4B+21.4%$3.6B+16.8%$3.1B+60.0%$1.9B+13.0%$1.7B-4.6%$1.8B+25.2%$1.4B+4.6%$1.4B-19.0%$1.7B+21.6%$1.4B+11.7%$1.3B
Net Income$16.1B+14.8%$14.0B+12.9%$12.4B+55.5%$8.0B+9.9%$7.3B+4.9%$6.9B+18.3%$5.9B-1.3%$5.9B-3.7%$6.2B+14.4%$5.4B+6.1%$5.1B
EPS (Basic)$3.62+15.2%$3.15+13.6%$2.77+57.1%$1.76+11.4%$1.58$2.97+20.3%$2.47+0.7%$2.45-1.6%$2.49+17.0%$2.13+7.8%$1.97
EPS (Diluted)$3.62+15.2%$3.14+13.7%$2.76+57.2%$1.76+11.4%$1.58$2.96+20.3%$2.46+0.7%$2.44-1.6%$2.48+17.0%$2.12+7.9%$1.97
Diluted Shares (Avg)4.45B-0.3%4.46B-0.7%4.49B-1.1%4.54B-1.3%4.61B2.34B-1.6%2.38B-1.9%2.42B-2.2%2.48B-2.2%2.53B-1.7%2.58B

Not reported in any period shown, so not listed: SG&A Expenses.

NONOF Balance Sheet

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

NONOF annual balance sheet
MetricFY2520-FFY2420-FFY2320-FFY2220-FFY2120-FFY2020-FFY1920-FFY1820-FFY1720-FFY1620-FFY1520-F
Total Assets$85.3B+32.0%$64.6B+38.5%$46.7B+34.5%$34.7B+17.2%$29.6B+24.3%$23.8B+26.2%$18.9B+11.0%$17.0B+2.8%$16.5B+19.4%$13.8B+3.6%$13.4B
Current Assets$27.1B+20.7%$22.5B+8.4%$20.7B+33.1%$15.6B+19.5%$13.0B+20.4%$10.8B+15.3%$9.4B+3.5%$9.1B-6.6%$9.7B+14.4%$8.5BN/A
Cash & Equivalents$4.2B+91.4%$2.2B+1.7%$2.1B+17.3%$1.8B+11.6%$1.6B-18.8%$2.0B-13.2%$2.3B-3.4%$2.4B-13.4%$2.8B+5.7%$2.6B+13.6%$2.3B
Inventory$7.8B+37.5%$5.7B+20.1%$4.7B+34.6%$3.5B+17.5%$3.0B-2.0%$3.0B+14.9%$2.7B+5.7%$2.5B+1.0%$2.5B+22.0%$2.0BN/A
Goodwill$3.1B+12.2%$2.8BN/AN/AN/AN/AN/AN/AN/AN/AN/A
Total Liabilities$54.8B+22.6%$44.7B+44.9%$30.9B+35.9%$22.7B+20.5%$18.8B+40.4%$13.4B+31.2%$10.2B+13.0%$9.0B+6.6%$8.5B+14.4%$7.4B+13.7%$6.5B
Current Liabilities$33.9B+12.2%$30.2B+20.0%$25.2B+44.7%$17.4B+14.9%$15.1B+31.1%$11.6B+30.3%$8.9B+6.6%$8.3B+9.4%$7.6B+12.9%$6.7BN/A
Non-Current Liabilities$20.9B+44.3%$14.5B+155.5%$5.7B+7.2%$5.3B+43.6%$3.7B+98.3%$1.9B+37.1%$1.4B+85.7%$731.3M-17.4%$885.5M+29.1%$686.0MN/A
Long-Term Debt$36.2B+91.1%$18.9B+249.7%$5.4B-16.5%$6.5B+88.5%$3.4B+622.8%$476.2M+5.3%$452.1Mn/m$0N/AN/AN/A
Total Equity$30.5B+53.1%$19.9B+25.9%$15.8B+31.7%$12.0B+11.5%$10.8B+3.4%$10.4B+20.3%$8.7B+8.8%$8.0B-1.1%$8.0B+25.2%$6.4B-6.0%$6.8B
Retained Earnings$30.7B+53.1%$20.0B+28.9%$15.6B+34.2%$11.6B+5.8%$11.0B+4.5%$10.5B+20.7%$8.7B+6.0%$8.2B+3.6%$7.9B+20.8%$6.5BN/A

Not reported in any period shown, so not listed: Short-Term Investments, Accounts Receivable, Long-Term Investments.

NONOF Cash Flow Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

NONOF annual cash flow statement
MetricFY2520-FFY2420-FFY2320-FFY2220-FFY2120-FFY2020-FFY1920-FFY1820-FFY1720-FFY1620-FFY1520-F
Operating Cash Flow$18.7B+11.5%$16.8B+3.9%$16.2B+42.4%$11.3B+35.6%$8.4B-2.0%$8.5B+21.5%$7.0B+2.7%$6.8B+3.0%$6.6B-3.1%$6.9B+23.1%$5.6B
Depreciation & Amortization$3.5B+30.2%$2.7B+89.9%$1.4B+31.9%$1.1B+15.5%$917.0M-3.0%$945.6M+11.2%$850.6M+41.2%$602.3M+17.2%$513.8M+13.4%$453.2M+5.2%$430.6M
Capital Expenditures$9.5B+44.4%$6.5B+70.9%$3.8B+119.2%$1.7B+81.2%$964.2M+0.7%$957.4M-28.7%$1.3B-9.2%$1.5B+20.1%$1.2B+22.8%$1.0B+32.0%$760.2M
Free Cash Flow$9.3B-9.6%$10.2B-16.9%$12.3B+28.4%$9.6B+29.6%$7.4B-2.3%$7.6B+33.3%$5.7B+6.0%$5.4B-0.9%$5.4B-7.5%$5.9B+21.7%$4.8B
Investing Cash Flow-$12.4Bn/m-$17.9Bn/m-$6.5Bn/m-$3.6Bn/m-$4.8Bn/m-$3.7Bn/m-$1.7Bn/m-$1.9Bn/m-$1.1Bn/m-$963.6Mn/m-$887.3M
Financing Cash Flow-$4.5B-468.2%$1.2Bn/m-$9.4Bn/m-$7.5Bn/m-$3.9Bn/m-$5.3Bn/m-$5.3Bn/m-$5.3Bn/m-$5.8Bn/m-$5.5Bn/m-$4.4B
Dividends Paid$8.1B+32.8%$6.1B+30.0%$4.7B+29.5%$3.6B+11.2%$3.3B-1.0%$3.3B+13.4%$2.9B-0.2%$2.9B-3.9%$3.0B-10.0%$3.4B+80.1%$1.9B
Share Buybacks$218.1M-92.2%$2.8B-36.9%$4.4B+28.2%$3.5B+17.1%$3.0B+6.8%$2.8B+20.2%$2.3B-3.5%$2.4B-12.2%$2.7B+27.3%$2.1B-14.8%$2.5B

Not reported in any period shown, so not listed: Stock-Based Compensation.

NONOF Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

NONOF annual financial ratios
MetricFY2520-FFY2420-FFY2320-FFY2220-FFY2120-FFY2020-FFY1920-FFY1820-FFY1720-FFY1620-FFY1520-F
Gross Margin81.0%-3.7pp84.7%+0.1pp84.6%+0.7pp83.9%+0.7pp83.2%-0.3pp83.5%0.0pp83.5%-0.7pp84.3%0.0pp84.2%-0.4pp84.6%-0.4pp85.0%
Operating Margin41.3%-2.9pp44.2%0.0pp44.2%+1.9pp42.3%+0.6pp41.6%-1.0pp42.6%-0.4pp43.0%+0.8pp42.3%-1.6pp43.8%+0.5pp43.3%-2.5pp45.8%
Net Margin33.1%-1.6pp34.8%-1.3pp36.0%+4.6pp31.4%-2.5pp33.9%+0.7pp33.2%+1.3pp31.9%-2.6pp34.5%+0.4pp34.1%+0.2pp33.9%+1.6pp32.3%
Return on Equity52.8%-17.6pp70.4%-8.2pp78.5%+12.0pp66.5%-1.0pp67.5%+1.0pp66.5%-1.1pp67.6%-6.9pp74.5%-2.0pp76.5%-7.2pp83.8%+9.6pp74.2%
Return on Assets18.9%-2.8pp21.7%-4.9pp26.6%+3.6pp23.0%-1.5pp24.6%-4.5pp29.1%-1.9pp31.0%-3.9pp34.9%-2.4pp37.3%-1.6pp38.9%+0.9pp38.0%
Current Ratio0.80+0.1x0.74-0.1x0.82-0.1x0.890.0x0.86-0.1x0.94-0.1x1.060.0x1.09-0.2x1.280.0x1.26N/A
Debt-to-Equity1.19+0.2x0.95+0.6x0.34-0.2x0.54+0.2x0.32+0.3x0.050.0x0.05+0.1x0.00N/AN/AN/A
Liabilities-to-Equity1.80-0.4x2.25+0.3x1.95+0.1x1.89+0.1x1.75+0.5x1.29+0.1x1.180.0x1.14+0.1x1.05-0.1x1.15+0.2x0.95
Asset Turnover0.57-0.1x0.62-0.1x0.740.0x0.730.0x0.72-0.2x0.88-0.1x0.970.0x1.01-0.1x1.09-0.1x1.150.0x1.18
FCF Margin19.1%-6.3pp25.4%-10.4pp35.8%-1.9pp37.7%+3.2pp34.6%-1.8pp36.3%+5.3pp31.0%-0.3pp31.3%+1.3pp30.0%-6.9pp36.9%+6.3pp30.6%

Note: The current ratio is below 1.0 (0.80), indicating current liabilities exceed current assets, which may suggest potential short-term liquidity concerns.

Frequently Asked Questions

What is NOVO NORDISK A/S B NEW's annual revenue?

NOVO NORDISK A/S B NEW (NONOF) reported $48.6B in total revenue for fiscal year 2025. This represents a 20.5% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is NOVO NORDISK A/S B NEW's revenue growing?

NOVO NORDISK A/S B NEW (NONOF) revenue grew by 20.5% year-over-year, from $40.3B to $48.6B in fiscal year 2025.

Is NOVO NORDISK A/S B NEW profitable?

Yes, NOVO NORDISK A/S B NEW (NONOF) reported a net income of $16.1B in fiscal year 2025, with a net profit margin of 33.1%.

NOVO NORDISK A/S B NEW (NONOF) reported diluted earnings per share of $3.62 for fiscal year 2025. This represents a 15.2% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

NOVO NORDISK A/S B NEW (NONOF) had EBITDA of $23.5B in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

As of fiscal year 2025, NOVO NORDISK A/S B NEW (NONOF) had $4.2B in cash and equivalents against $36.2B in long-term debt.

NOVO NORDISK A/S B NEW (NONOF) had a gross margin of 81.0% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.

NOVO NORDISK A/S B NEW (NONOF) had an operating margin of 41.3% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.

NOVO NORDISK A/S B NEW (NONOF) had a net profit margin of 33.1% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

NOVO NORDISK A/S B NEW (NONOF) has a return on equity of 52.8% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

NOVO NORDISK A/S B NEW (NONOF) generated $9.3B in free cash flow during fiscal year 2025. This represents a -9.6% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

NOVO NORDISK A/S B NEW (NONOF) generated $18.7B in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

NOVO NORDISK A/S B NEW (NONOF) had $85.3B in total assets as of fiscal year 2025, including both current and long-term assets.

NOVO NORDISK A/S B NEW (NONOF) invested $9.5B in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

NOVO NORDISK A/S B NEW (NONOF) invested $8.2B in research and development during fiscal year 2025.

Yes, NOVO NORDISK A/S B NEW (NONOF) spent $218.1M on share buybacks during fiscal year 2025, returning capital to shareholders by reducing shares outstanding.

NOVO NORDISK A/S B NEW (NONOF) had a current ratio of 0.80 as of fiscal year 2025, which is below 1.0, which may suggest potential liquidity concerns.

NOVO NORDISK A/S B NEW (NONOF) had a debt-to-equity ratio of 1.19 as of fiscal year 2025. We compute it as long-term debt divided by total shareholder equity, where long-term debt is the noncurrent part of the company's borrowings, so debt due within the next twelve months is not counted.

NOVO NORDISK A/S B NEW (NONOF) had a liabilities-to-equity ratio of 1.80 as of fiscal year 2025, which is total liabilities divided by total shareholder equity. Total liabilities counts every obligation on the balance sheet (payables, deposits, insurance reserves and deferred taxes as well as borrowings), so this ratio usually runs well above debt-to-equity.

NOVO NORDISK A/S B NEW (NONOF) had a return on assets of 18.9% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

NOVO NORDISK A/S B NEW (NONOF) trades at 10.7x earnings, its market capitalization divided by $16.1B net income, FY2025. The market capitalization is $171.9B as of Oct 29, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

NOVO NORDISK A/S B NEW (NONOF) trades at 3.5x sales, its market capitalization divided by $48.6B revenue, FY2025. The market capitalization is $171.9B as of Oct 29, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

NOVO NORDISK A/S B NEW (NONOF) has an Altman Z-Score of 3.63, placing it in the Safe Zone (low bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.

NOVO NORDISK A/S B NEW (NONOF) has a Piotroski F-Score of 4 out of 8 computable signals; 1 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

NOVO NORDISK A/S B NEW (NONOF) has an earnings quality ratio of 1.16x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

NOVO NORDISK A/S B NEW (NONOF) has an interest coverage ratio of 30.34x, meaning it can comfortably cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.

Back to top